Literature DB >> 18566968

Cost-benefit analysis involving addictive goods: contingent valuation to estimate willingness-to-pay for smoking cessation.

David L Weimer1, Aidan R Vining, Randall K Thomas.   

Abstract

The valuation of changes in consumption of addictive goods resulting from policy interventions presents a challenge for cost-benefit analysts. Consumer surplus losses from reduced consumption of addictive goods that are measured relative to market demand schedules overestimate the social cost of cessation interventions. This article seeks to show that consumer surplus losses measured using a non-addicted demand schedule provide a better assessment of social cost. Specifically, (1) it develops an addiction model that permits an estimate of the smoker's compensating variation for the elimination of addiction; (2) it employs a contingent valuation survey of current smokers to estimate their willingness-to-pay (WTP) for a treatment that would eliminate addiction; (3) it uses the estimate of WTP from the survey to calculate the fraction of consumer surplus that should be viewed as consumer value; and (4) it provides an estimate of this fraction. The exercise suggests that, as a tentative first and rough rule-of-thumb, only about 75% of the loss of the conventionally measured consumer surplus should be counted as social cost for policies that reduce the consumption of cigarettes. Additional research to estimate this important rule-of-thumb is desirable to address the various caveats relevant to this study. Copyright (c) 2008 John Wiley & Sons, Ltd.

Mesh:

Year:  2009        PMID: 18566968     DOI: 10.1002/hec.1365

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  6 in total

1.  Causal Spousal Health Spillover Effects and Implications for Program Evaluation.

Authors:  Jason Fletcher; Ryne Marksteiner
Journal:  Am Econ J Econ Policy       Date:  2017-11

2.  Consumer willingness to invest money and time for benefits of lifestyle behaviour change: an application of the contingent valuation method.

Authors:  Adrienne F G Alayli-Goebbels; Job van Exel; André J H A Ament; Nanne K de Vries; Sandra D M Bot; Johan L Severens
Journal:  Health Expect       Date:  2014-08-18       Impact factor: 3.377

3.  A Cross-sectional Examination of What Smokers Perceive to be Important and Their Willingness to Pay for Tobacco Cessation Medications.

Authors:  Shanta R Dube; Michael F Pesko; Xin Xu
Journal:  J Public Health Manag Pract       Date:  2016 Jan-Feb

4.  Tobacco Regulation and Cost-Benefit Analysis: How Should We Value Foregone Consumer Surplus?

Authors:  Helen G Levy; Edward C Norton; Jeffrey A Smith
Journal:  Am J Health Econ       Date:  2018-01-23

5.  Cost benefit analysis of two policy options for cannabis: status quo and legalisation.

Authors:  Marian Shanahan; Alison Ritter
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

6.  When health policy and empirical evidence collide: the case of cigarette package warning labels and economic consumer surplus.

Authors:  Anna V Song; Paul Brown; Stanton A Glantz
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 11.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.